Bode U, Buchen S, Warmuth-Metz M, Pietsch T, Bach F, Fleischhack G. Final report of a phase II trial of nimotuzumab in the treatment of refractory and relapsed high-grade gliomas in children and adolescents. Hematol Meeting Rep [Internet]. 2009 Jun. 22 [cited 2024 Nov. 23];1(6). Available from: https://www.pagepress.org/journals/hmr/article/view/675